Image

Global Neuromodulation Market – Industry Trends and Forecast to 2029

Healthcare

Image

Global Neuromodulation Market – Industry Trends and Forecast to 2029

  • Healthcare
  • Upcoming Report
  • Mar 2022
  • Global
  • 350 Pages
  • No of Tables: 220
  • No of Figures: 60

Global Neuromodulation Market – Industry Trends and Forecast to 2029

Market Size in USD Billion

CAGR :  % Diagram

Diagram Forecast Period 2021–2029
Diagram Market Size (Base Year) USD 6.47 Billion
Diagram Market Size (Forecast Year) USD 15.57 Billion
Diagram CAGR %

Major Markets Players

  • Medtronic
  • Boston Scientific Corporation
  • NEVRO CORP
  • Cyberonics
  • Inspire Medical Systems

Global Neuromodulation Market, By Technology (Internal Neuromodulation, External Neuromodulation), Application (Spinal Cord Stimulation, Deep Brain Stimulation, Sacral Nerve Stimulation, Vagus Nerve Stimulation, Gastric Electrical Stimulation, Transcutaneous Electrical Nerve Stimulation, Repetitive Transcranial Magnetic Stimulation, Respiratory Electrical Stimulation), Biomaterial (Ceramics Biomaterials, Metallic Biomaterials, Polymeric Biomaterials), End-User (Hospitals, Clinics, Home Healthcare) – Industry Trends and Forecast to 2029

Neuromodulation Market

Global Neuromodulation Market Analysis and Size

The market for neuromodulation is estimated to increase rapidly over the forecast period. Neuromodulation devices are one of medicine's fastest-growing fields, involving a wide range of professionals and affecting hundreds of thousands of patients with a wide range of illnesses around the world. Neuromodulation devices have become more important in the treatment of chronic pain patients. These devices are designed to alleviate the unpleasant sensory experience of pain and the functional and behavioral consequences of pain. Therefore, these factors will enhance the demand for neuromodulation technology in the market.

  • Data Bridge Market Research analyses that the neuromodulation market was valued at USD 6.47 billion in 2021 and is expected to reach USD 15.57 billion by 2029, registering a CAGR of 11.60% during the forecast period of 2022 to 2029. The market report curated by the Data Bridge Market Research team includes in-depth expert analysis, patient epidemiology, pipeline analysis, pricing analysis, and regulatory framework.

Global Neuromodulation Market Definition

Neuromodulation is an intracranial electrical neuromodulation therapy that the FDA has approved for the treatment of most neurological diseases, including bladder control, headache, tremors, chronic pain, stroke, minimally conscious state, and spinal cord injury, which are most common in the elderly population. Many newcomers to the neuromodulation business are looking into using technology to treat obesity, depression, leg pain, treatment-resistant hypertension, sexual dysfunction, urinary tract diseases, heart failure, and drug addiction, among other conditions.

Report Metric

Details

Forecast Period

2022 to 2029

Base Year

2021

Historic Years

2020 (Customizable to 2019 - 2014)

Quantitative Units

Revenue in USD Billion, Volumes in Units, Pricing in USD

Segments Covered

Technology (Internal Neuromodulation, External Neuromodulation), Application (Spinal Cord Stimulation, Deep Brain Stimulation, Sacral Nerve Stimulation, Vagus Nerve Stimulation, Gastric Electrical Stimulation, Transcutaneous Electrical Nerve Stimulation, Repetitive Transcranial Magnetic Stimulation, Respiratory Electrical Stimulation), Biomaterial (Ceramics Biomaterials, Metallic Biomaterials, Polymeric Biomaterials), End-User (Hospitals, Clinics, Home Healthcare)

Countries Covered

U.S., Canada and Mexico in North America, Germany, France, U.K., Netherlands, Switzerland, Belgium, Russia, Italy, Spain, Turkey, Rest of Europe in Europe, China, Japan, India, South Korea, Singapore, Malaysia, Australia, Thailand, Indonesia, Philippines, Rest of Asia-Pacific (APAC) in the Asia-Pacific (APAC), Saudi Arabia, U.A.E, South Africa, Egypt, Israel, Rest of Middle East and Africa (MEA) as a part of Middle East and Africa (MEA), Brazil, Argentina and Rest of South America as part of South America.

Market Players Covered

Medtronic (Ireland), Boston Scientific Corporation (US), NEVRO CORP (US), Cyberonics, Inc. (US), Inspire Medical Systems, Inc. (US), SPR Therapeutics (US), ALEVA NEUROTHERAPEUTICS SA (Switzerland), Bioness Inc. (US), ReShape Lifesciences, Inc. (US), LivaNova PLC (UK), NeuroPace, Inc. (US), Synapse Biomedical Inc. (US), Soterix Medical Inc. (US), Accellent Technologies, Inc. (US), Abbott (US), Bioventus (US), Soterix Medical Inc. (US), Integer Holdings Corporation (US), NEVRO CORP. (US), NeuroSigma, Inc. (US), NeuroPace, Inc. (US), Neuronetics (US), BioControl Medical (Israel)

Neuromodulation Market Dynamics

Drivers

  • Increasing incidences of neurological diseases

The rising incidences of neurological diseases will cushion the market's growth rate. Along with this, the increase in variety of headache and brain diseases patients will enhance the demand for neuromodulation market.

  • Rise in the growth of neurostimulators

The neuromodulation market is being driven by the increase in growth of neurostimulators within the treatment of depression and sleep apnea.

Furthermore, the rising awareness about neurodegenerative diseases will be a major factor influencing the growth of the neuromodulation market. Along with this, increasing urbanization and the rising geriatric population are also the driving factors accelerating the growth of the neuromodulation market. Also, the rise in the changing lifestyle and increasing expenditure on healthcare infrastructure are the major market drivers that will further escalate the growth of neuromodulation market. Another significant factor that will cushion the neuromodulation market's growth rate is the rising gastric, chronic and nerve disability conditions.

Opportunities

  • Growing number of R&D activities

Moreover, the rising number of research and development activities will provide beneficial opportunities for the neuromodulation market growth. Along with this, increase in extensive new indications and target applications linked with robust product pipeline offered by various market players will flourish the growth rate of neuromodulation market.  

Moreover, growing focus of manufacturers on the adoption of advanced technologies and increase in the number of emerging markets will further provide beneficial opportunities for the neuromodulation market growth during the forecast period.

Restraints/Challenges Global Neuromodulation Market

  • High cost associated with neuromodulation devices

However, the high cost associated with neuromodulation devices and procedures will impede the neuromodulation market's growth rate.

On the other hand, the dearth of skilled professionals in under-developed nations will challenge the neuromodulation market. Additionally, emergence of unfavourable conditions due to COVID-19 outbreak and lack of awareness will act as restrain and further impede the growth rate of market during the forecast period of 2022-2029.

This neuromodulation market report provides details of new recent developments, trade regulations, import-export analysis, production analysis, value chain optimization, market share, impact of domestic and localized market players, analyses opportunities in terms of emerging revenue pockets, changes in market regulations, strategic market growth analysis, market size, category market growths, application niches and dominance, product approvals, product launches, geographic expansions, technological innovations in the market. To gain more info on the neuromodulation market contact Data Bridge Market Research for an Analyst Brief, our team will help you take an informed market decision to achieve market growth.

COVID-19 Impact on Neuromodulation Market

The fast spread of coronavirus caused the COVID-19 pandemic outbreak. The transmission of this virus has a significant impact on many parts of the globe. Countries have yet to recover from this infection, and a new form of the virus has emerged as a big issue for them. The global economy is causing issues for businesses and governments alike. Apart from the healthcare industry, the pandemic has significantly impacted many sectors. The healthcare sector is experiencing a surge in demand as a result of the pandemic, and the reason is clear. With the rising number of health problems caused by the pandemic, the healthcare sector will grow even more. Neuromodulation devices are used to treat a wide range of illnesses. Many people have encountered serious health difficulties as a result of the virus; as a result, demand for neuromodulation devices will increase. However, the enforcement of lockdown is expected to cause problems in the manufacturing industry for neuromodulation devices.

Recent Development

  • In March 2021, Helius Medical's Portable Neuromodulation Stimulator was approved by the US Food and Drug Administration for the short-term therapy of gait deficits caused by multiple sclerosis.

Global Neuromodulation Market Scope

The neuromodulation market is segmented on the basis of technology, application, biomaterial, and end-user. The growth amongst these segments will help you analyze meagre growth segments in the industries and provide the users with a valuable market overview and market insights to help them make strategic decisions for identifying core market applications.

Technology

  • Internal Neuromodulation
  • External Neuromodulation

On the basis of technology, the neuromodulation market is segmented into internal neuromodulation and external neuromodulation.

Application

  • Spinal Cord Stimulation
  • Deep Brain Stimulation
  • Sacral Nerve Stimulation
  • Vagus Nerve Stimulation
  • Gastric Electrical Stimulation
  • Transcutaneous Electrical Nerve Stimulation
  • Repetitive Transcranial Magnetic Stimulation
  • Respiratory Electrical Stimulation

On the basis of application, the neuromodulation market is segmented into spinal cord stimulation, deep brain stimulation, sacral nerve stimulation, vagus nerve stimulation, gastric electrical stimulation, transcutaneous electrical nerve stimulation, repetitive transcranial magnetic stimulation, and respiratory electrical stimulation.

Biomaterial

  • Ceramics Biomaterials
  • Metallic Biomaterials
  • Polymeric Biomaterials

On the basis of biomaterials, the neuromodulation market is segmented into ceramics biomaterials, metallic biomaterials, and polymeric biomaterials.

End-User

  • Hospitals
  • Clinics
  • Home Healthcare

On the basis of end-user, the neuromodulation market is segmented into hospitals, clinics, and home healthcare.

Neuromodulation Market Regional Analysis/Insights

The neuromodulation market is analysed and market size insights and trends are provided by country, technology, application, biomaterial, and end-user as referenced above.

The countries covered in the neuromodulation market report are U.S., Canada and Mexico in North America, Germany, France, U.K., Netherlands, Switzerland, Belgium, Russia, Italy, Spain, Turkey, Rest of Europe in Europe, China, Japan, India, South Korea, Singapore, Malaysia, Australia, Thailand, Indonesia, Philippines, Rest of Asia-Pacific (APAC) in the Asia-Pacific (APAC), Saudi Arabia, U.A.E, South Africa, Egypt, Israel, Rest of Middle East and Africa (MEA) as a part of Middle East and Africa (MEA), Brazil, Argentina and Rest of South America as part of South America.

North America dominates the neuromodulation market because of the presence of major key players in this region. Additionally, the growing acceptance of advanced technologies will flourish the market's growth rate in this region. 

Asia-Pacific is expected to grow during the forecast period due to the rising occurrence of established players in this region. Along with this, increasing awareness about mental health and surging prevalence of neurological diseases will flourish the market's growth rate in this region.

The country section of the report also provides individual market impacting factors and changes in regulation in the market domestically that impacts the current and future trends of the market. Data points like down-stream and upstream value chain analysis, technical trends and porter's five forces analysis, case studies are some of the pointers used to forecast the market scenario for individual countries. Also, the presence and availability of global brands and their challenges faced due to large or scarce competition from local and domestic brands, impact of domestic tariffs and trade routes are considered while providing forecast analysis of the country data.   

Healthcare Infrastructure growth Installed base and New Technology Penetration

The neuromodulation market also provides you with detailed market analysis for every country growth in healthcare expenditure for capital equipment, installed base of different kind of products for neuromodulation market, impact of technology using life line curves and changes in healthcare regulatory scenarios and their impact on the neuromodulation market. The data is available for historic period 2010-2020.

Competitive Landscape and Neuromodulation Market Share Analysis

The Neuromodulation market competitive landscape provides details by competitor. Details included are company overview, company financials, revenue generated, market potential, investment in research and development, new market initiatives, global presence, production sites and facilities, production capacities, company strengths and weaknesses, product launch, product width and breadth, application dominance. The above data points provided are only related to the companies' focus related to neuromodulation market.

Some of the major players operating in the neuromodulation market Medtronic (Ireland), Boston Scientific Corporation (US), NEVRO CORP (US), Cyberonics, Inc. (US), Inspire Medical Systems, Inc. (US), SPR Therapeutics (US), ALEVA NEUROTHERAPEUTICS SA (Switzerland), Bioness Inc. (US), ReShape Lifesciences, Inc. (US), LivaNova PLC (UK), NeuroPace, Inc. (US), Synapse Biomedical Inc. (US), Soterix Medical Inc. (US), Accellent Technologies, Inc. (US), Abbott (US), Bioventus (US), Soterix Medical Inc. (US), Integer Holdings Corporation (US), NEVRO CORP. (US), NeuroSigma, Inc. (US), NeuroPace, Inc. (US), Neuronetics (US), and BioControl Medical (Israel), among others.

Research Methodology : Global Neuromodulation Market

Data collection and base year analysis is done using data collection modules with large sample sizes. The market data is analyzed and estimated using market statistical and coherent models. Also market share analysis and key trend analysis are the major success factors in the market report. To know more please request an analyst call or can drop down your inquiry.

The key research methodology used by DBMR research team is data triangulation which involves data mining, analysis of the impact of data variables on the market, and primary (industry expert) validation. Apart from this, data models include Vendor Positioning Grid, Market Time Line Analysis, Market Overview and Guide, Company Positioning Grid, Company Market Share Analysis, Standards of Measurement, Global versus Regional and Vendor Share Analysis. To know more about the research methodology, drop in an inquiry to speak to our industry experts https://www.databridgemarketresearch.com/speak-to-analyst/?dbmr=global-neuromodulation-market


SKU-

Please fill in the below form for detailed Table of Content

By clicking the "Submit" button, you are agreeing to the Data Bridge Market Research Privacy Policy and Terms and Conditions

Please fill in the below form for detailed List of Table

By clicking the "Submit" button, you are agreeing to the Data Bridge Market Research Privacy Policy and Terms and Conditions

Please fill in the below form for detailed List of Figure

By clicking the "Submit" button, you are agreeing to the Data Bridge Market Research Privacy Policy and Terms and Conditions

Please fill in the below form for Infographics

By clicking the "Submit" button, you are agreeing to the Data Bridge Market Research Privacy Policy and Terms and Conditions

Research Methodology:

Data collection and base year analysis are done using data collection modules with large sample sizes. The stage includes obtaining market information or related data through various sources and strategies. It includes examining and planning all the data acquired from the past in advance. It likewise envelops the examination of information inconsistencies seen across different information sources. The market data is analysed and estimated using market statistical and coherent models. Also, market share analysis and key trend analysis are the major success factors in the market report. To know more, please request an analyst call or drop down your inquiry.

The key research methodology used by DBMR research team is data triangulation which involves data mining, analysis of the impact of data variables on the market and primary (industry expert) validation. Data models include Vendor Positioning Grid, Market Time Line Analysis, Market Overview and Guide, Company Positioning Grid, Patent Analysis, Pricing Analysis, Company Market Share Analysis, Standards of Measurement, Global versus Regional and Vendor Share Analysis. To know more about the research methodology, drop in an inquiry to speak to our industry experts.

Please fill in the below form for Research Methodology

By clicking the "Submit" button, you are agreeing to the Data Bridge Market Research Privacy Policy and Terms and Conditions

Customization Available:

Data Bridge Market Research is a leader in advanced formative research. We take pride in servicing our existing and new customers with data and analysis that match and suits their goal. The report can be customized to include price trend analysis of target brands understanding the market for additional countries (ask for the list of countries), clinical trial results data, literature review, refurbished market and product base analysis. Market analysis of target competitors can be analyzed from technology-based analysis to market portfolio strategies. We can add as many competitors that you require data about in the format and data style you are looking for. Our team of analysts can also provide you data in crude raw excel files pivot tables (Fact book) or can assist you in creating presentations from the data sets available in the report.

Please fill in the below form for Available Customization

By clicking the "Submit" button, you are agreeing to the Data Bridge Market Research Privacy Policy and Terms and Conditions

FREQUENTLY ASK QUESTIONS

The Neuromodulation Market is projected USD 15.57 billion during the forecast period of 2022 to 2029.
The Neuromodulation Market is to Grow at a CAGR of 11.60% During the Forecast Period of 2022 to 2029.
The major players in the Neuromodulation Market are Medtronic (Ireland), Boston Scientific Corporation (US), NEVRO CORP (US), Cyberonics, Inc. (US), Inspire Medical Systems, Inc. (US), SPR Therapeutics (US), ALEVA NEUROTHERAPEUTICS SA (Switzerland), Bioness Inc. (US), etc.
The Countries Covered in the Neuromodulation Market Report are U.S., Canada and Mexico in North America, Germany, France, U.K., Netherlands, Switzerland, Belgium, Russia, Italy, Spain, Turkey, Rest of Europe in Europe, China, Japan, India, South Korea, etc.
Free Sample Report

CHOOSE LICENCE TYPE

  • 7000.00
  • 4800.00
  • 3000.00
  • 8000.00
  • 12000.00

Why Choose Us

Industry Coverage

DBMR works across the globe in multiple industries which equip us with knowledge across verticals and provide our clients with insights not only from their industry but how other industries will impact their ecosystem.

Regional Coverage

Coverage of Data Bridge is not restricted to developed or emerging economies. We work across the globe covering the largest array of countries where no other market research or business consulting firm has ever conducted research; creating growth opportunities for our clients in areas which are still unknown.

Technology Coverage

In today’s world, technology drives the market sentiment, so our vision is to provide our clients insights not only for developed technologies but upcoming and disrupting technological changes throughout the product lifecycle by enabling them with unforeseen opportunities in the market which will create disruption in their industry. This leads to innovation and our clients to come out as winners.

Goal Oriented Solutions

DBMR goal is to help our clients achieve their goals through our solutions; hence we formatively create the most appropriate solutions for our client needs, saving time and efforts for them to drive their grand strategies.

Unparallel Analyst Support

Our analysts take pride in our clients’ success. Unlike others, we believe in working along our clients to achieve their goals with 24 hours analyst support determining the correct needs and inspire innovation through service.

Banner

Client Testimonials